Sheba Introduces FibroScan630 for Precise Liver and Spleen Assessment
This innovative technology measures liver scarring (fibrosis) and fat content (steatosis) with unparalleled precision.
The FibroScan630 is not only capable of assessing liver elasticity but also evaluates spleen stiffness, crucial for determining the severity of portal hypertension, a complication of liver diseases. Sheba is the first public medical center in Israel to implement this technology and the second overall in the country.
Dr. Ehud (Udi) Zigmond, who oversees this advanced service at Sheba’s Institute of Gastroenterology, leads the team dedicated to providing exceptional care with FibroScan630. This tool allows for accurate assessments that can sometimes replace invasive procedures like gastroscopy, improving both patient comfort and diagnostic accuracy.
At Sheba, our commitment to cutting-edge technology ensures that we deliver the highest standard of care for patients with liver and spleen conditions.
More Posts
Sheba’s Prof. Amitai Ziv Awarded by IMSH for Medical Simulation Excellence
Prof. Amitai Ziv, Founder of MSR-Azrieli Medical Simulation Center and Director of the Rehabilitation Hospital at Sheba Medical Center, has received...
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
